What Can We Learn From The Investigation Of Misconduct?

[Editor's note: Discussions of research misconduct are becoming more and more prevalent, in the halls of academic and research institutions as well as on the front pages of newspapers. But few in the scientific community have experienced the issue as personally as the six authors of the now infamous Cell paper, among them MIT's David Baltimore and Tufts' Thereza ImanishiKari. Since May 1986, when Margot O'Toole, a postdoc working in Imanishi-Kari's lab at MIT, first raised doubts about some of t


Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

In the most recent hearing, held last month, Rep. John Dingell (DMich.), chairman of the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee, asked several people to describe how their institutions handled—or mishandled—the allegations brought by O'Toole.

What follows are excerpts from the testimonies of key figures in the dispute. The comments are not intended to prove or disprove specific allegations, nor are they meant to provide any kind of overview of this one case. Rather, they are reprinted here to provide a glimpse into how scientists at the center of such a dispute do their jobs, how they see themselves, and how they are viewed by others; as well as to illuminate some personal elements of a bitter and protracted debate.]

So what is the case against us? That there are legitimate disagreements over the results of our work? This I recognize and encourage. That ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo